OR WAIT null SECS
April 24, 2024
Developing freeze-drying processes requires patience and deep product and process understanding.
April 16, 2024
The LNP success in mRNA vaccines leads to their establishment as a standard in mRNA delivery.
November 02, 2023
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
October 12, 2023
The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China.
October 04, 2023
The prize was awarded jointly to Katalin Karikó and Drew Weissman for their groundbreaking discovery regarding modification of the bases in mRNA.
September 26, 2023
The companies plan on targeting the production of abundant, low-cost messenger RNA from C1-cells.
August 17, 2023
An mRNA conversation about the recent past, current hot topics, and probable future.
August 03, 2023
A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.
July 18, 2023
Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.
June 14, 2023
The new excipients manufacturing facility is expected to be completed in 2025.